While government-owned pharma companies are ailing from years of neglect, some have rolled up their sleeves and joined Indias uphill battle against Covid, with plans to manufacture drugs that are used for treatment of Covid-19 patients or to produce vaccines that can shield people from the dreaded SARS-CoV-2 virus.